Co-expression of both let-7d-3p and let-7d-5p was found to contribute to colon cancer by exclusively inhibiting KRAS by let-7d-3p, and promoting IGF1R and THBS1 expression by let-7d-5p53. Here, KRAS is linked to colonic neoplasm.